首页>
外国专利>
Cholinesterase determn. in plasma or erythrocyte samples - based on conversion of radio-labelled acetyl-choline in undiluted samples
Cholinesterase determn. in plasma or erythrocyte samples - based on conversion of radio-labelled acetyl-choline in undiluted samples
展开▼
机译:胆碱酯酶确定。血浆或红细胞样品中的血浆-基于未稀释样品中放射性标记的乙酰胆碱的转化
展开▼
页面导航
摘要
著录项
相似文献
摘要
Determn. of cholinesterase activity in undiluted plasma and erythrocyte samples is effected by (a) incubating the sample with (14C-acetyl)choline at 25 deg.C. and pH 7.4; (b) adding EtOH/HOAc to stop the reaction; (c) evaporating off any 14C-acetic acid formed; (d) measuring the difference in radioactivity between the evapd. material and residue; and (e) calculating the cholinesterase activity (in miromole/min.ml) from the radioactivity difference, the specific radioactivity of the (14C-acetyl)choline, the incubation time and the sample vol.. The sample vol. is 0.1 ml. For determn. of butyrylcholinesterase in plasma samples, the substrate concn. is 9.1 mM. For determn. of acetylcholinesterase in erythrocyte samples, the substrate concn. is 3.6 mM. USE/ADVANTAGE - The process is useful for monitoring the therapy of Alzheimer's disease using reversible cholinesterase inhibitors. Errors due to sample dilution are eliminated.
展开▼